The overall goal of this study is to use the new tau tracer, MK6240, to determine tau burden (neurofibrillary tangles) in Alzheimer’s Disease (AD) vulnerable regions of the brain through PET scanning. This will be accomplished by employing imaging techniques (MRI and PET) and collecting biochemical biomarkers related to AD. Examining this pathology may provide an explanation for the very earliest cognitive changes that occur in AD.
Tau Imaging with MK6240: A Possible Biomarker for Alzheimer’s Disease
This project was funded by: NIH
The term of this project was: May 2017 to May 2018
The number of subjects scanned during this project was: 20